CN113615681A - Frozen stock solution and frozen stock method for immune cells - Google Patents
Frozen stock solution and frozen stock method for immune cells Download PDFInfo
- Publication number
- CN113615681A CN113615681A CN202110997925.8A CN202110997925A CN113615681A CN 113615681 A CN113615681 A CN 113615681A CN 202110997925 A CN202110997925 A CN 202110997925A CN 113615681 A CN113615681 A CN 113615681A
- Authority
- CN
- China
- Prior art keywords
- immune cells
- solution
- cooling
- speed
- frozen stock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a frozen stock solution and a frozen stock method of immune cells, in particular to a frozen stock solution and a frozen stock method of immune cells, which comprise FBS, DMSO, 1640 culture solution, low molecular heparin calcium and antioxidation; a cryopreservation method of immune cell cryopreservation liquid comprises the following steps: step one, storing; placing the immune cells into a freezing tube, then adding the freezing solution, slowly blowing and uniformly mixing, and placing the freezing tube into a cooling chamber; step two, cooling for the first time; firstly reducing the temperature to 3 ℃ and keeping the temperature for 4 min; then cooling to-3 ℃ at the speed of-2 ℃/min; finally, cooling to-40 ℃ at the speed of-11 ℃/min; step three, firstly heating up to-30 ℃ at the speed of-16 ℃/min for the first time; fourthly, cooling for the second time; keeping at-30 deg.C for 4 min; then cooling to-50 ℃ at the speed of-2 ℃/min; finally, the temperature is reduced to minus 80 ℃ at the speed of minus 10 ℃/min; -80 ℃ for 5 days; fifthly, storing; and finally storing the mixture in a liquid nitrogen tank for freezing.
Description
Technical Field
The invention relates to a preparation method of a Miao medicine, namely a Chinese mugwort moxa stick, and particularly relates to frozen stock solution and a frozen stock method of immune cells.
Background
Cell freezing is a technique of placing cells in a low-temperature environment to slow down cell metabolism so as to achieve long-term storage. The principle is that the cells are placed in liquid nitrogen at the temperature of 196 ℃ below zero for ultralow temperature preservation, so that the cells can be temporarily separated from the growth state to preserve the characteristics of the cells, and the cells can be used by reviving the cells when needed. When the cells are frozen, the protective agent is added into the cell suspension, so that the freezing point of the solution can be lowered, water in the cells permeates out of the cells under the condition of slow freezing, and the formation of ice crystals in the cells is reduced, thereby avoiding the damage of the cells in the freezing process. At present, the cryopreservation of cells is mainly performed under the ultralow temperature condition of liquid nitrogen at the temperature of-196 ℃, the metabolic function of the cells is arrested under the ultralow temperature condition, the cells can be preserved for a long time, and when the cells are needed, the cryopreserved cells are taken out and quickly thawed in water bath at the temperature of 37 ℃, so that the activity and the function of the cells can be recovered. However, the existing immune cell cryopreservation method only solves the cryopreservation of stem cells and tumor cells, but the immune cell cryopreservation method cannot be well solved. Due to the cell structure and the cell characteristics of immune cells, when the conventional cell cryopreservation solution and the conventional cell cryopreservation method are used for cryopreserving the immune cells, the immune cells are easily damaged by ice crystals, the survival rate of the recovered cells is low, the cell proliferation quantity is insufficient, the cells are easy to age, the efficiency is low, the cryopreservation quality is low, the activity and the survival rate of the recovered cells are poor, and the like.
Disclosure of Invention
The invention provides a frozen stock solution and a frozen stock method for immune cells.
In order to solve the problems, the invention provides a frozen stock solution of immune cells and a freezing method thereof, wherein the frozen stock solution comprises FBS, DMSO, 1640 culture solution, low-molecular heparin calcium and antioxidation.
The cryopreservation solution and the cryopreservation method for the immune cells, provided by the invention, further have the following technical characteristics:
further, the volume part of the FBS is 10-20. More preferably the parts by volume of FBS are 11, 12, 13, 14, 15, 16, 17, 18, 19.
Further, the volume fraction of the DMSO is 10-20. More preferably the volume fraction of DMSO is 11, 12, 13, 14, 15, 16, 17, 18, 19.
Furthermore, the 1640 culture solution is 40-60 parts by volume. More preferably 1640 parts of culture medium are 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59.
Further, the volume fraction of the low molecular heparin calcium is 8-5. More preferably 1640 culture medium parts by volume 7, 6.
Further, the volume part of the antioxidant is 2-5. More preferably the antioxidant is present in 3, 4 parts by volume.
Further, the antioxidant is vitamin C injection.
Further, the frozen stock solution is prepared according to the following proportion: according to the volume parts, 10-20 parts of FBS, 10-20 parts of DMSO, 40-60 parts of 1640 culture solution, 8-5 parts of low molecular heparin calcium with the concentration of 1500-.
Further, the cryopreservation method of the immune cell cryopreservation solution comprises the following steps:
step one, storage
Placing the immune cells into a freezing tube, then adding the freezing solution, slowly blowing and uniformly mixing, and placing the freezing tube into a cooling chamber;
step two, cooling for the first time
Firstly reducing the temperature to 3 ℃ and keeping the temperature for 4 min;
then cooling to-3 ℃ at the speed of-2 ℃/min;
finally, cooling to-40 ℃ at the speed of-11 ℃/min;
step three, first temperature rise
Firstly, heating to-30 ℃ at the speed of-16 ℃/min;
the fourth step, the second cooling
Keeping at-30 deg.C for 4 min;
then cooling to-50 ℃ at the speed of-2 ℃/min;
finally, the temperature is reduced to minus 80 ℃ at the speed of minus 10 ℃/min;
-80 ℃ for 5 days;
the fifth step, storage
And finally storing the mixture in a liquid nitrogen tank for freezing.
The invention has the beneficial effects that: the cryopreservation solution and the cryopreservation method for the immune cells are simple in formula, each component has respective functions, and the components are mutually matched and cooperated, so that the cryopreservation effect of the immune cells can be obviously improved, the intracellular water can not be crystallized when the cells are close to a freezing point, and the activity and the cell proliferation capacity of the recovered cells are not influenced.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without creative efforts.
FIG. 1 is a graph showing the ratio of components of a frozen stock solution of an immune cell according to the present invention;
FIG. 2 is a flow chart of a method for freezing immune cell freezing medium according to the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention relates to a frozen stock solution and a frozen stock method of immune cells, in particular to a frozen stock solution and a frozen stock method of immune cells, which comprise FBS, DMSO, 1640 culture solution, low molecular heparin calcium and antioxidant.
The volume parts of the FBS are 10-20.
The volume part of the DMSO is 10-20.
The 1640 culture solution is 40-60 parts by volume.
The volume part of the low molecular heparin calcium is 8-5.
The volume part of the antioxidant is 2-5.
The antioxidant is vitamin C injection.
Preparing the frozen stock solution according to the following proportion: according to the volume parts, 10-20 parts of FBS, 10-20 parts of DMSO, 40-60 parts of 1640 culture solution, 8-5 parts of low molecular heparin calcium with the concentration of 1500-.
A cryopreservation method of immune cell cryopreservation liquid comprises the following steps:
step one, storage
Placing the immune cells into a freezing tube, then adding the freezing solution, slowly blowing and uniformly mixing, and placing the freezing tube into a cooling chamber;
step two, cooling for the first time
Firstly reducing the temperature to 3 ℃ and keeping the temperature for 4 min;
then cooling to-3 ℃ at the speed of-2 ℃/min;
finally, cooling to-40 ℃ at the speed of-11 ℃/min;
step three, first temperature rise
Firstly, heating to-30 ℃ at the speed of-16 ℃/min;
the fourth step, the second cooling
Keeping at-30 deg.C for 4 min;
then cooling to-50 ℃ at the speed of-2 ℃/min;
finally, the temperature is reduced to minus 80 ℃ at the speed of minus 10 ℃/min;
-80 ℃ for 5 days;
the fifth step, storage
And finally storing the mixture in a liquid nitrogen tank for freezing.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (9)
1. A frozen stock solution and a frozen stock method of immune cells are characterized in that: comprises FBS, DMSO, 1640 culture solution, low molecular heparin calcium and antioxidant.
2. The cryopreservation solution and method for immune cells according to claim 1, wherein: the volume parts of the FBS are 10-20.
3. The cryopreservation solution and method for immune cells according to claim 1, wherein: the volume part of the DMSO is 10-20.
4. The cryopreservation solution and method for immune cells according to claim 1, wherein: the 1640 culture solution is 40-60 parts by volume.
5. The cryopreservation solution and method for immune cells according to claim 1, wherein: the volume part of the low molecular heparin calcium is 8-5.
6. The cryopreservation solution and method for immune cells according to claim 1, wherein: the volume part of the antioxidant is 2-5.
7. The cryopreservation solution and method for immune cells according to claim 1, wherein: the antioxidant is vitamin C injection.
8. The cryopreservation solution for immune cells and the cryopreservation method thereof according to any one of claims 1 to 7, wherein: preparing the frozen stock solution according to the following proportion: according to the volume parts, 10-20 parts of FBS, 10-20 parts of DMSO, 40-60 parts of 1640 culture solution, 8-5 parts of low molecular heparin calcium with the concentration of 1500-.
9. A cryopreservation method of immune cell cryopreservation liquid is characterized by comprising the following steps:
step one, storage
Placing the immune cells into a freezing tube, then adding the freezing solution, slowly blowing and uniformly mixing, and placing the freezing tube into a cooling chamber;
step two, cooling for the first time
Firstly reducing the temperature to 3 ℃ and keeping the temperature for 4 min;
then cooling to-3 ℃ at the speed of-2 ℃/min;
finally, cooling to-40 ℃ at the speed of-11 ℃/min;
step three, first temperature rise
Firstly, heating to-30 ℃ at the speed of-16 ℃/min;
the fourth step, the second cooling
Keeping at-30 deg.C for 4 min;
then cooling to-50 ℃ at the speed of-2 ℃/min;
finally, the temperature is reduced to minus 80 ℃ at the speed of minus 10 ℃/min;
-80 ℃ for 5 days;
the fifth step, storage
And finally storing the mixture in a liquid nitrogen tank for freezing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110997925.8A CN113615681A (en) | 2021-08-27 | 2021-08-27 | Frozen stock solution and frozen stock method for immune cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110997925.8A CN113615681A (en) | 2021-08-27 | 2021-08-27 | Frozen stock solution and frozen stock method for immune cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113615681A true CN113615681A (en) | 2021-11-09 |
Family
ID=78388213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110997925.8A Pending CN113615681A (en) | 2021-08-27 | 2021-08-27 | Frozen stock solution and frozen stock method for immune cells |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113615681A (en) |
Citations (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0891134A1 (en) * | 1996-03-25 | 1999-01-20 | Advanced Reproduction Technologies, Inc. | Use of arabinogalactan in cell cryopreservation media |
| WO2004010780A2 (en) * | 2002-07-30 | 2004-02-05 | General Biotechnology, Llc | Innocuous intracellular ice |
| CN104026118A (en) * | 2013-11-13 | 2014-09-10 | 杭州易文赛生物技术有限公司 | Immunization cell frozen stock solution, preparation method and application |
| CN104542578A (en) * | 2015-02-05 | 2015-04-29 | 广州赛莱拉干细胞科技股份有限公司 | Cell preservation solution and preparation method and applications thereof |
| CN105052895A (en) * | 2015-09-01 | 2015-11-18 | 广州赛莱拉干细胞科技股份有限公司 | LAK cell preservation solution, preparation method thereof and LAK cell preservation method |
| CN105123671A (en) * | 2015-07-24 | 2015-12-09 | 广州赛莱拉干细胞科技股份有限公司 | Cell cryo-preserved liquid, application, and immune cell cryo-preservation method |
| CN105638642A (en) * | 2016-01-27 | 2016-06-08 | 上海润泉生物技术有限公司 | Immune cell cryopreservation solution and application thereof |
| CN106665560A (en) * | 2017-01-16 | 2017-05-17 | 哈尔滨医科大学 | Direct venous re-transfusion immune cell cryopreservation medium and application thereof |
| CN106942200A (en) * | 2017-03-24 | 2017-07-14 | 深圳市合康生物科技股份有限公司 | One kind freezes protection liquid and its application |
| CN107047541A (en) * | 2017-05-31 | 2017-08-18 | 东莞市保莱生物科技有限公司 | A kind of immunocyte frozen stock solution and immunocyte cryopreservation methods |
| CN108142412A (en) * | 2017-12-27 | 2018-06-12 | 重庆斯德姆生物技术有限公司 | A kind of immunocyte frozen stock solution and cryopreservation methods |
| CN108513973A (en) * | 2018-05-30 | 2018-09-11 | 广州沙艾生物科技有限公司 | A kind of storage method and cells frozen storing liquid of immunocyte |
| US20190037832A1 (en) * | 2016-04-08 | 2019-02-07 | Tianjin University | Cell Cryopreservation Protective Composition, Use Thereof, and Cell Cryopreservation Method |
| CN110495447A (en) * | 2019-09-10 | 2019-11-26 | 湖南思为康医药有限公司 | A kind of method immunocyte glass frozen preservation protection liquid and freeze immunocyte |
| CN111387174A (en) * | 2020-01-17 | 2020-07-10 | 广东先康达生物科技有限公司 | Immune cell cryopreservation liquid and immune cell cryopreservation method |
| CN111616139A (en) * | 2020-06-02 | 2020-09-04 | 广州沙艾生物科技有限公司 | Storage liquid of autoimmune cells, preparation method and application thereof |
| CN112167241A (en) * | 2019-07-04 | 2021-01-05 | 陕西佰傲干细胞再生医学有限公司 | Stem cell freezing medium and stem cell freezing and recovering method |
| CN112220734A (en) * | 2020-11-16 | 2021-01-15 | 郑州源创吉因实业有限公司 | Skin-care spray containing stem cell active factors and preparation method thereof |
| CN112806354A (en) * | 2021-01-18 | 2021-05-18 | 圣至同合(北京)生物科技有限公司 | Immune cell cryopreservation liquid as well as preparation method and application thereof |
| WO2021159073A1 (en) * | 2020-02-06 | 2021-08-12 | The George Washington University | Methods and compositions for cryopreservation of cell therapies |
-
2021
- 2021-08-27 CN CN202110997925.8A patent/CN113615681A/en active Pending
Patent Citations (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0891134A1 (en) * | 1996-03-25 | 1999-01-20 | Advanced Reproduction Technologies, Inc. | Use of arabinogalactan in cell cryopreservation media |
| WO2004010780A2 (en) * | 2002-07-30 | 2004-02-05 | General Biotechnology, Llc | Innocuous intracellular ice |
| CN104026118A (en) * | 2013-11-13 | 2014-09-10 | 杭州易文赛生物技术有限公司 | Immunization cell frozen stock solution, preparation method and application |
| CN104542578A (en) * | 2015-02-05 | 2015-04-29 | 广州赛莱拉干细胞科技股份有限公司 | Cell preservation solution and preparation method and applications thereof |
| CN105123671A (en) * | 2015-07-24 | 2015-12-09 | 广州赛莱拉干细胞科技股份有限公司 | Cell cryo-preserved liquid, application, and immune cell cryo-preservation method |
| CN105052895A (en) * | 2015-09-01 | 2015-11-18 | 广州赛莱拉干细胞科技股份有限公司 | LAK cell preservation solution, preparation method thereof and LAK cell preservation method |
| CN105638642A (en) * | 2016-01-27 | 2016-06-08 | 上海润泉生物技术有限公司 | Immune cell cryopreservation solution and application thereof |
| US20190037832A1 (en) * | 2016-04-08 | 2019-02-07 | Tianjin University | Cell Cryopreservation Protective Composition, Use Thereof, and Cell Cryopreservation Method |
| CN106665560A (en) * | 2017-01-16 | 2017-05-17 | 哈尔滨医科大学 | Direct venous re-transfusion immune cell cryopreservation medium and application thereof |
| CN106942200A (en) * | 2017-03-24 | 2017-07-14 | 深圳市合康生物科技股份有限公司 | One kind freezes protection liquid and its application |
| CN107047541A (en) * | 2017-05-31 | 2017-08-18 | 东莞市保莱生物科技有限公司 | A kind of immunocyte frozen stock solution and immunocyte cryopreservation methods |
| CN108142412A (en) * | 2017-12-27 | 2018-06-12 | 重庆斯德姆生物技术有限公司 | A kind of immunocyte frozen stock solution and cryopreservation methods |
| CN108513973A (en) * | 2018-05-30 | 2018-09-11 | 广州沙艾生物科技有限公司 | A kind of storage method and cells frozen storing liquid of immunocyte |
| CN112167241A (en) * | 2019-07-04 | 2021-01-05 | 陕西佰傲干细胞再生医学有限公司 | Stem cell freezing medium and stem cell freezing and recovering method |
| CN110495447A (en) * | 2019-09-10 | 2019-11-26 | 湖南思为康医药有限公司 | A kind of method immunocyte glass frozen preservation protection liquid and freeze immunocyte |
| CN111387174A (en) * | 2020-01-17 | 2020-07-10 | 广东先康达生物科技有限公司 | Immune cell cryopreservation liquid and immune cell cryopreservation method |
| WO2021159073A1 (en) * | 2020-02-06 | 2021-08-12 | The George Washington University | Methods and compositions for cryopreservation of cell therapies |
| CN111616139A (en) * | 2020-06-02 | 2020-09-04 | 广州沙艾生物科技有限公司 | Storage liquid of autoimmune cells, preparation method and application thereof |
| CN112220734A (en) * | 2020-11-16 | 2021-01-15 | 郑州源创吉因实业有限公司 | Skin-care spray containing stem cell active factors and preparation method thereof |
| CN112806354A (en) * | 2021-01-18 | 2021-05-18 | 圣至同合(北京)生物科技有限公司 | Immune cell cryopreservation liquid as well as preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 魏福兰等: "深低温冻存对牙周膜干细胞膜片增殖和分化能力的影响", 《口腔生物医学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108207930B (en) | Cocktail type cryoprotectant and application thereof | |
| Taylor et al. | New approaches to cryopreservation of cells, tissues, and organs | |
| CN102640745B (en) | Ultralow-temperature cryopreservation and recovery method for embryonic materials | |
| CN103462175B (en) | Fresh micro-freezing liquid used for keeping food fresh | |
| CN102812988B (en) | Fresh-keeping method of phyllostachys pracecox shoots | |
| CN104145944B (en) | A kind of stalwart blood clam sperm super-low temperature freezing is preserved and Activiation method | |
| CN109601602B (en) | Secondary refrigerant for quick freezing of liquid and preparation method thereof | |
| CN109329271A (en) | A kind of clinical mescenchymal stem cell freezen protective liquid and preparation method thereof | |
| CN103865495A (en) | Refrigerating liquid for refrigerating foods via impregnation process | |
| CN112167243B (en) | Erythrocyte cryopreservation liquid and rapid cryopreservation method | |
| CN102428910A (en) | Protecting liquid for freezing and storing human umbilical cord Wharton jelly tissue block | |
| CN106942200A (en) | One kind freezes protection liquid and its application | |
| CN108967416B (en) | Cryoprotectant and application thereof | |
| CN113615681A (en) | Frozen stock solution and frozen stock method for immune cells | |
| CN113925049A (en) | Cell preservation solution for maintaining cell activity and preparation method and application thereof | |
| CN111226910A (en) | Vitrification refrigerating fluid and freezing method for ovum or embryo in cleavage stage | |
| CN106857497A (en) | A kind of seven methods preserved with grouper sperm super-low temperature | |
| CN116235847A (en) | Low-temperature cryopreservation tube, and grouper low-temperature cryopreservation method and application | |
| CN102657152B (en) | Ultra-low temperature freezing preservation method for embryo materials | |
| CN117378599B (en) | Ultralow temperature cryopreservation and activation method for tetraploid sperm of Pacific oyster | |
| CN114424766B (en) | Ultra-low temperature liver preservation solution and preservation method | |
| CN112970829A (en) | Frozen meat quality improvement method | |
| CN111771875A (en) | Cell cryopreservation liquid and cryopreservation method | |
| CN117256604B (en) | Dolphin semen cryopreservation agent and semen cryopreservation method | |
| CN117814212A (en) | Cryopreservation method of neural stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211109 |
|
| RJ01 | Rejection of invention patent application after publication |